Wednesday, BioMarin Pharmaceutical Inc. (BMRN) reported third-quarter net income of $6.6 million or $0.06 per share, up from $0.8 million or $0.01 per share a year ago. Non-GAAP net income increased to $15.5 million or $0.13 per share from $8.2 million or $0.08 per share.
Revenue increased 11% to $80.8 million for the quarter. Analysts expected earnings of $0.01 per share on revenues of $81.92 million for the quarter.
For fiscal 2009, BioMarin adjusted its revenues revenue guidance to range between $313 million and $327 million from the previous guidance of $311 to $336 million. Analysts currently expect revenues of $324.77 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.